[lung]The role of durvalumab in patients with stage 3 lung cancer in a real hospital Published 2022-11-18 Download video MP4 360p Download video MP4 720p Recommendations 07:13 Stage 3 Lung Cancer: Symptoms, Treatment. Life Expectancy | Episode 17 06:38 Working but poor: millions in work and in poverty 43:41 Episode 29: Bone & Brain Metastases in Neuroendocrine Cancer 20:14 For HCPs: Data Update From IMFINZI® (durvalumab)’s PACIFIC Trial and Perspective from Dr Decker 06:47 Immunotherapy and the side effects 19:51 Cancer Survivor Story: Non-Hodgkin Lymphoma | The Patient Story 35:19 DocTalk Podcast: Understanding Lung Nodules 41:53 Stem cell transplant: Patients reflect on their transplant journey 02:10 POSEIDON: 4 year follow up of durvalumab and tremelimumab in NSCLC 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 22:57 Terminal Breast Cancer Made Me Live Life To The Fullest | Only Human 06:07 PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC 20:17 The Fear of Starting a New Treatment-Our Therapists Said the Same Thing-Caregiver-Stage IV Cancer 20:52 Radiotherapy to the Head and Neck: A Guide for patients and their carers 24:54 Non-Hodgkin Lymphoma Survivor Story: Mantle Cell Lymphoma | Shari's Story, Part 1 (Diagnosis) 06:32 Lung Cancer / Pathology - Squamous cell carcinoma #usmle #neetpg #fmge #mbbs 29:02 Sampling and Evaluating Lung Nodules and Masses: Expert Q&A 03:17 TOPAZ-1: the addition of durvalumab to chemotherpay for the treatment of BTC in the 1st-line setting 1:26:39 Standing on the Shoulders of Giants 29:21 A Doctor Becomes the Patient and Tells His Story of Being Diagnosed with Terminal Brain Cancer Similar videos 06:50 Implications for Using Durvalumab in Stage 3 NSCLC 06:48 Durvalumab improves PFS in stage III lung cancer 02:32 Durvalumab after #Chemoradiotherapy in Stage III Non-Small-Cell Lung #Cancer. | #MedicalVideos 03:39 What is durvalumab’s future as a treatment option in lung cancer? 01:29 How can durvalumab be used in NSCLC? 17:01 Preparing a Patient for Treatment with IMFINZI® (durvalumab) 04:25 Durvalumab Tolerability in Non–Small Cell Lung Cancer 08:57 MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD+ II-III NSCLC 06:37 Surgical perspective on neoadjuvant IO for resectable stage III NSCLC 01:59 Using real-world data to optimize patient pathways in lung cancer 52:55 Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer 05:43 Helping Unresectable Stage III NSCLC Patients Through Treatment | For the Lung Cancer Nursing Team 08:16 Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients 07:34 PX Lung Seg14 Immunotherapy rev 05:53 Targeted Therapy in Non-Small Cell Lung Cancer 06:47 Case 1: Immunotherapy in Locally Advanced NSCLC 02:15 How a new treatment could cure stage 4 lung cancer 02:53 Lung Cancer Video Library - Das - What is the Role of Immunotherapy for Unresectable Stage lll NSCLC 03:30 Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC) More results